[Symptoms of anxiety and depression in atopic eczema/dermatitis syndrome].
The presence of chronic disease is a risk factor for the development of mood disturbances and panic disorders. They can influence the course of disease and effectiveness of therapy. Depression may be the cause of making light doctor's advice. Anxious patients often aggravate symptoms of the disease.


OBJECTIVE
To study symptoms of anxiety and depression in patients suffering from atopic eczema/dermatitis syndrome (ZAZS). Material. We studied 38 patients suffering from adequately controlled moderate ZAZS and 62 volunteers in the control group.


METHODS
Mental status of subjects was assessed by means of State and Trait Anxiety Inventory (STAI) and Beck Depression Inventory (BDI) questionnaires.


RESULTS
ZAZS patients demonstrated higher intensity of anxiety (as a trait and as a state) than healthy subjects. Intensity and prevalence of depression in the atopic eczema/ dermatitis syndrome group was higher than in the control group.


CONCLUSIONS
Patients suffering from atopic/eczema dermatitis syndrome are pre-disposed to anxiety and depression manifestation. Even adequately controlled symptoms of atopic/eczema dermatitis syndrome may be the cause of those disturbances' occurrence.
Brzoza
Zenon
Z
Katedra i Klinika Chorób Wewnetrznych, Alergologii i Immunologii Klinicznej SAM w Zabrzu.
Badura-Brzoza
Karina
K
Nowakowski
Marek
M
Matysiakiewicz
Jerzy
J
Rogala
Barbara
B
Hese
Robert T
RT
D000223:Adaptation, Psychological; D000328:Adult; D001007:Anxiety / Q000209:etiology*; D016022:Case-Control Studies; D003863:Depression / Q000209:etiology*; D003876:Dermatitis, Atopic / Q000523:psychology* / Q000628:therapy; D005260:Female; D006304:Health Status; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D012307:Risk Factors; D012720:Severity of Illness Index; D013315:Stress, Psychological / Q000209:etiology; D011795:Surveys and Questionnaires